Katharina von Baumbach

Age 26; estimated US$6.6bn. Family pharmaceutical ownership. She is another individually estimated member of the Boehringer Ingelheim ownership family. Shared family history explains the similar source of wealth without turning this into a combined-family valuation. The image is an original industry illustration, not a portrait.